News
Proteus Syndrome Market Insight, Epidemiology and Market Forecast - 2034The Proteus Syndrome market is entering a pivotal decade, driven by ...
ANI Pharmaceuticals (ANIP) stock drops as its Iluvien implant fails in a clinical trial versus Eylea marketed by Regeneron ...
Morse Asset Management Inc has significantly increased its stake in Regeneron Pharmaceuticals, boosting its share count by a ...
Three high schoolers from Flower Mound, Texas, won a $50,000 scholarship at the Regeneron International Science Fair for ...
Me’s privacy ombudsman secured court approval to retain WilmerHale in the DNA testing company’s Chapter 11 case despite an ...
Short-term stock returns are largely driven by the perception of near-term earnings per share. Read more here.
The path to market for Roche’s astegolimab became more uncertain after the investigational antibody failed to significantly ...
Bailard Inc. drastically reduced its stake in Regeneron Pharmaceuticals, offloading 69.9% of its shares in the first quarter.
Commerce Secretary Howard Lutnick said Trump's new tariff policies are focused on ending the U.S.'s reliance on foreign supply of key pharmaceutical products. "We are proud that AstraZeneca has made ...
The U.K. biopharmaceutical giant’s plans include a proposal for a new drug substance manufacturing center focused on ...
A new genetic test, based on data from more than five million people, can identify people at risk of severe obesity. The test can be performed on children before their genetic risk starts to shape ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results